Green Cross Holdings Corporation (005257.KS)
KRW 23150.0
(1.09%)
KRW 23150.0
(1.09%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 458.68 Billion KRW | -21.16% |
| 2022 | 581.8 Billion KRW | 11.76% |
| 2021 | 520.59 Billion KRW | 18.15% |
| 2020 | 440.62 Billion KRW | 18.35% |
| 2019 | 372.31 Billion KRW | 7.65% |
| 2018 | 345.86 Billion KRW | -5.71% |
| 2017 | 366.8 Billion KRW | 4.18% |
| 2016 | 352.07 Billion KRW | 3.86% |
| 2015 | 338.99 Billion KRW | 9.18% |
| 2014 | 310.49 Billion KRW | 12.95% |
| 2013 | 274.89 Billion KRW | 8.41% |
| 2012 | 253.57 Billion KRW | -2.04% |
| 2011 | 258.85 Billion KRW | -17.74% |
| 2010 | 314.69 Billion KRW | 16.66% |
| 2009 | 269.74 Billion KRW | 32.07% |
| 2008 | 204.24 Billion KRW | 13.21% |
| 2007 | 180.4 Billion KRW | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 121.01 Billion KRW | 51.1% |
| 2024 Q1 | 80.09 Billion KRW | -17.17% |
| 2024 Q3 | 464.9 Billion KRW | 20.25% |
| 2023 FY | 458.68 Billion KRW | -21.16% |
| 2023 Q4 | 96.69 Billion KRW | -31.35% |
| 2023 Q3 | 140.85 Billion KRW | 0.05% |
| 2023 Q2 | 140.78 Billion KRW | 41.55% |
| 2023 Q1 | 99.46 Billion KRW | -20.66% |
| 2022 Q4 | 125.36 Billion KRW | -25.9% |
| 2022 Q1 | 145.37 Billion KRW | 15.55% |
| 2022 Q2 | 141.87 Billion KRW | -2.41% |
| 2022 FY | 581.8 Billion KRW | 11.76% |
| 2022 Q3 | 169.18 Billion KRW | 19.25% |
| 2021 Q3 | 185.51 Billion KRW | 58.85% |
| 2021 Q4 | 125.81 Billion KRW | -32.18% |
| 2021 Q1 | 92.48 Billion KRW | -11.98% |
| 2021 FY | 520.59 Billion KRW | 18.15% |
| 2021 Q2 | 116.78 Billion KRW | 26.28% |
| 2020 Q3 | 142.86 Billion KRW | 37.35% |
| 2020 Q1 | 88.68 Billion KRW | 6.71% |
| 2020 Q4 | 105.06 Billion KRW | -26.46% |
| 2020 FY | 440.62 Billion KRW | 18.35% |
| 2020 Q2 | 104 Billion KRW | 17.28% |
| 2019 FY | 372.31 Billion KRW | 7.65% |
| 2019 Q4 | 83.11 Billion KRW | -29.21% |
| 2019 Q2 | 98.58 Billion KRW | 34.65% |
| 2019 Q3 | 117.4 Billion KRW | 19.1% |
| 2019 Q1 | 73.21 Billion KRW | -0.86% |
| 2018 Q3 | 103.02 Billion KRW | 17.56% |
| 2018 FY | 345.86 Billion KRW | -5.71% |
| 2018 Q4 | 73.84 Billion KRW | -28.32% |
| 2018 Q2 | 87.63 Billion KRW | 7.72% |
| 2018 Q1 | 81.35 Billion KRW | 2.25% |
| 2017 FY | 366.8 Billion KRW | 4.18% |
| 2017 Q4 | 79.56 Billion KRW | -29.34% |
| 2017 Q3 | 112.61 Billion KRW | 11.75% |
| 2017 Q2 | 100.77 Billion KRW | 36.45% |
| 2017 Q1 | 73.85 Billion KRW | -14.3% |
| 2016 FY | 352.07 Billion KRW | 3.86% |
| 2016 Q3 | 103.82 Billion KRW | 11.74% |
| 2016 Q4 | 86.17 Billion KRW | -17.0% |
| 2016 Q2 | 92.91 Billion KRW | 34.35% |
| 2016 Q1 | 69.16 Billion KRW | -12.18% |
| 2015 FY | 338.99 Billion KRW | 9.18% |
| 2015 Q4 | 78.75 Billion KRW | -25.37% |
| 2015 Q1 | 65.22 Billion KRW | -12.26% |
| 2015 Q3 | 105.52 Billion KRW | 17.92% |
| 2015 Q2 | 89.49 Billion KRW | 37.2% |
| 2014 Q4 | 74.34 Billion KRW | -27.36% |
| 2014 Q3 | 102.34 Billion KRW | 47.15% |
| 2014 Q1 | 64.26 Billion KRW | 5.6% |
| 2014 Q2 | 69.54 Billion KRW | 8.22% |
| 2014 FY | 310.49 Billion KRW | 12.95% |
| 2013 Q3 | 94.34 Billion KRW | 49.82% |
| 2013 Q1 | 56.71 Billion KRW | 6.76% |
| 2013 Q4 | 60.85 Billion KRW | -35.5% |
| 2013 FY | 274.89 Billion KRW | 8.41% |
| 2013 Q2 | 62.97 Billion KRW | 11.03% |
| 2012 Q1 | 56.75 Billion KRW | -7.2% |
| 2012 Q4 | 53.12 Billion KRW | -38.51% |
| 2012 Q3 | 86.39 Billion KRW | 50.77% |
| 2012 Q2 | 57.3 Billion KRW | 0.97% |
| 2012 FY | 253.57 Billion KRW | -2.04% |
| 2011 Q4 | 61.15 Billion KRW | -30.24% |
| 2011 FY | 258.85 Billion KRW | -17.74% |
| 2011 Q3 | 87.66 Billion KRW | 53.5% |
| 2011 Q2 | 57.1 Billion KRW | 7.61% |
| 2011 Q1 | 53.07 Billion KRW | 0.0% |
| 2010 Q1 | 131.95 Billion KRW | 15.29% |
| 2010 Q3 | 77.82 Billion KRW | 38.33% |
| 2010 Q4 | - KRW | -100.0% |
| 2010 FY | 314.69 Billion KRW | 16.66% |
| 2010 Q2 | 56.26 Billion KRW | -57.36% |
| 2009 Q2 | 53.35 Billion KRW | 19.89% |
| 2009 Q1 | 44.5 Billion KRW | -15.98% |
| 2009 Q3 | 57.43 Billion KRW | 7.66% |
| 2009 Q4 | 114.45 Billion KRW | 99.26% |
| 2009 FY | 269.74 Billion KRW | 32.07% |
| 2008 Q4 | 52.96 Billion KRW | -2.09% |
| 2008 FY | 204.24 Billion KRW | 13.21% |
| 2008 Q3 | 54.09 Billion KRW | 5.52% |
| 2008 Q2 | 51.26 Billion KRW | 11.62% |
| 2008 Q1 | 45.92 Billion KRW | 6.04% |
| 2007 Q1 | 40.76 Billion KRW | 0.0% |
| 2007 Q3 | 51.01 Billion KRW | 13.3% |
| 2007 Q4 | 43.3 Billion KRW | -15.11% |
| 2007 FY | 180.4 Billion KRW | 0.0% |
| 2007 Q2 | 45.02 Billion KRW | 10.45% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ORIENT BIO Inc. | 9.58 Billion KRW | -4685.783% |
| Green Cross Holdings Corporation | 603.58 Billion KRW | 24.006% |
| Pharmicell Co., Ltd. | 14.95 Billion KRW | -2967.088% |
| Green Cross Corporation | 458.68 Billion KRW | 0.0% |
| GeneOne Life Science, Inc. | -14.98 Billion KRW | 3161.128% |
| Celltrion, Inc. | 1010.9 Billion KRW | 54.626% |
| Samsung Biologics Co.,Ltd. | 1802.76 Billion KRW | 74.556% |
| SK bioscience Co.,Ltd. | 142.24 Billion KRW | -222.469% |
| SK Biopharmaceuticals Co., Ltd. | 308.37 Billion KRW | -48.744% |
| Prestige BioPharma Limited | 689.07 Million KRW | -66465.869% |